DGX241220P180000
- 23.02
- 0.000.00%
クエスト・ダイアグノスティクスのニュース一覧
突迎利好!医药巨头异动!
What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock?
ロバート・W・ベアードはクエスト・ダイアグノスティクス(DGX.US)のレーティングを強気に据え置き、目標株価を181ドルに引き下げた
ロバート・W・ベアードのアナリストEric Coldwellは$Quest Diagnostics(DGX.US)$のレーティングを強気に据え置き、目標株価を182ドルから181ドルに引き下げた。TipRanksのデータによると、このアナリストの最近1年間の的中率は53.9%、平均リターンは4.5%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リターンに
Quest Diagnostics Stock Hits 52-week High at $165.11
Baird Adjusts Price Target on Quest Diagnostics to $181 From $182, Keeps Outperform Rating
Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue?
Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson's Disease
DigitalOwl Announces Strategic Collaboration With ExamOne to Improve Record Retrieval and Analysis
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
Quest Diagnostics Declares Quarterly Cash Dividend
Press Release: Quest Diagnostics Declares Quarterly Cash Dividend
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
How Is The Market Feeling About Quest Diagnostics?
Is Now An Opportune Moment To Examine Quest Diagnostics Incorporated (NYSE:DGX)?
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts